Literature DB >> 11070155

Automation of fluorescence in situ hybridization pretreatment: a comparative study of different sample types.

K Jacobson1, A Thompson, G Browne, C Shasserre, S A Seelig, W King.   

Abstract

BACKGROUND: In fluorescence in situ hybridization (FISH) applications, the efficiency of probe hybridization is greatly enhanced by treating the cell or tissue preparation with a variety of reagents that make the target permeable while preserving important morphological features. Pretreatment protocols can be very labor intensive, adding cost to the test. The automation of specimen pretreatment eliminates human variation in the procedure through standardization of such variables as treatment times and temperatures. METHODS AND
RESULTS: We developed an instrument, the VP 2000 Processor, that can process up to 50 specimens simultaneously under computer control. In this comparative FISH study of matched specimens, one set was processed according to the manual pretreatment protocol and compared with specimens processed by the VP 2000. Processed specimen types included paraffin-embedded breast tissue, uncultured amniocytes, bone marrow, peripheral-blood lymphocytes, and uroepithelial cells recovered from urine. Data show equivalent or brighter and more specific overall signal quality compared with matched manually executed controls.
CONCLUSIONS: The automation of sample pretreatment for FISH provides a superior, more consistent level of performance than the manual format.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070155     DOI: 10.1054/modi.2000.9731

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  3 in total

1.  A new method for real-time evaluation of pepsin digestion of paraffin-embedded tissue sections, prior to fluorescence in situ hybridisation.

Authors:  Xiaojing Teng; Shuhong Zhang; Wei Liu; Kuo Bi; Lei Zhang
Journal:  Virchows Arch       Date:  2017-02-25       Impact factor: 4.064

2.  Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.

Authors:  Shizhen Zhang; Yan Wang; Jolanta Bondaruk; Tadeusz Majewski; Hui Yao; Sangkyou Lee; June Goo Lee; David Cogdell; Yair Lotan; Colin Dinney; Peng Wei; Keith Baggerly; Bogdan Czerniak
Journal:  Eur Urol Focus       Date:  2018-02-07

3.  Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.

Authors:  Lyndsay N Harris; Gloria Broadwater; Maysa Abu-Khalaf; David Cowan; Ann D Thor; Daniel Budman; Constance T Cirrincione; Donald A Berry; Eric P Winer; Clifford A Hudis; Daniel F Hayes; Paula Friedman; Matthew Ellis; Lynn Dressler
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.